💨 Abstract
Insulet Corp. reported second-quarter earnings of $22.5 million, or 32 cents per share, on August 7, 2025. Adjusted earnings were $1.17 per share, surpassing Wall Street expectations of 93 cents per share. The company's revenue was $649.1 million, exceeding forecasts of $615.5 million. Insulet develops insulin infusion systems.
Courtesy: WTOP Staff
Suggested
Wilson and Dart lead Giants to 34-25 preseason win over Bills -
Revolution blank D.C. United 2-0 to end nine-match winless streak -
CeeDee Lamb takes big hit from sprinting official while WR is in street clothes on the sideline -
Winning numbers drawn in Saturday’s Maryland Cash Pop -
Mariano Rivera tears his Achilles tendon in Yankees’ Old-Timers’ Day game -
NASCAR-Xfinity Mission 200 At The Glen Results -
¿Qué pasó en el atentado contra Miguel Uribe Turbay, senador colombiano? Lo que se sabe del ataque y los sospechosos -
Los viajes de algunas figuras de Morena ponen en duda el discurso de austeridad del partido -
People with developmental disabilities seeing Medicaid coverage lapse more often in Maryland -
Teens allegedly trash store at Hechinger Mall in Northeast DC -